BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+12.57%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$750M
AUM Growth
+$750M
(+54%)
Cap. Flow
+$209M
Cap. Flow
% of AUM
27.87%
Top 10 Holdings %
Top 10 Hldgs %
28.71%
Holding
137
New
15
Increased
36
Reduced
39
Closed
5
Top Buys
| 1 |
Align Technology
ALGN
|
$15.6M |
| 2 |
Elevance Health
ELV
|
$14.9M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$13.3M |
| 4 |
Amgen
AMGN
|
$11.8M |
| 5 |
Centene
CNC
|
$10.1M |
Top Sells
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$4.67M |
| 2 |
Stryker
SYK
|
$4.32M |
| 3 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
$2.11M |
| 4 |
Becton Dickinson
BDX
|
$1.83M |
| 5 |
Zimmer Biomet
ZBH
|
$1.83M |
Sector Composition
| 1 | Healthcare | 92.09% |
| 2 | Financials | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Penumbra
PEN
$10.5B
| $417K | 0.06% |
5,000
| – | – |
|
127
Novavax
NVAX
$1.2B
| $416K | 0.06% |
16,250
| – | – |
|
|
WBMD
128
DELISTED
WebMD Health Corp.
WBMD
| $390K | 0.05% |
7,400
| – | – |
|
|
AAC
129
DELISTED
AAC Holdings, Inc.
AAC
| $384K | 0.05% |
45,000
| – | – |
|
130
Myriad Genetics
MYGN
$633M
| $250K | 0.03% |
13,000
-1,000
| -7% | -$19.2K |
|
131
Surgery Partners
SGRY
$2.89B
| $205K | 0.03% |
10,500
-4,500
| -30% | -$87.9K |
|
132
Cerus
CERS
$251M
| $134K | 0.02% |
+30,000
| New | +$134K |
|
|
ARIA
133
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| – | – |
-375,000
| Closed | -$4.67M |
|
|
INSY
134
DELISTED
Insys Therapeutics, Inc.
INSY
| – | – |
-115,000
| Closed | -$1.06M |
|
|
EIGR
135
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| – | – |
-111
| Closed | -$39K |
|
136
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$727M
| – | – |
-1,259
| Closed | -$788K |
|
137
ProShares Ultra NASDAQ Biotechnology
BIB
$55.7M
| – | – |
-20,500
| Closed | -$818K |
|